Melissa M. Harwood Ph.D.
SociaEXPERIENCE
J.D., University of Washington School of Law
Ph.D., Chemistry, University of Washington
B.S., Chemistry, University of Utah
Awards
- The Legal 500 United States
- Recommended, Patents: Prosecution (including re-examination and post-grant proceedings) (2023)
- Best Lawyers, Biotechnology and Life Sciences Practice, 2022
- Best Lawyers, Patent Law, 2022
Publications
- Author, "Federal Circuit Raises the Enablement Bar for Antibody Patents," IAM, 2021
- Co-author, "Technology Transfer Considerations for Stem Cell Technologies," Society for Technology Management, 2009, 4(2), 8-10
- Author, "Article III Controversy May Exist Under the Declaratory Judgment Act for Licensees Not Violating a License Agreement: MedImmune v. Genentech," CASRIP Newsletter, Autumn/Winter 2007, 14(1)
Seminars
Prior Experience
Prior to her legal career, Melissa worked as a synthetic bench chemist for a life sciences company and as a postdoctoral research scientist in the University of Washington's Department of Chemistry.